European regulator investigates SUICIDE RISK associated with popular weight-loss drugs – NaturalNews.com
The European Medicines Agency (EMA), the European equivalent of the U.S. Food and Drug Administration, is conducting a review of some weight-loss drugs after being alerted about new complications and a possible link to thoughts of suicide and self-harm among users. EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) initially examined data on people using liraglutide (Saxenda) and semaglutide […]
Source: naturalnews.com